| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.6M | -34.0% |
| Cost of Revenue | $5.4M | -33.3% |
| Gross Profit | $8.2M | -34.5% |
| R&D Expense | $4.7M | -25.2% |
| SG&A Expense | $8.3M | -19.9% |
| Operating Income | -$55.4M | -66.2% |
| Pre-tax Income | -$59.3M | -76.7% |
| Income Tax | -$716K | +68.3% |
| Net Income | -$79.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $878K | -93.7% |
| Accounts Receivable | $675K | -51.9% |
| Current Assets | $14.9M | -18.3% |
| Total Assets | $19.5M | -79.4% |
| Current Liabilities | $22.7M | -22.1% |
| Long-term Debt | $14.6M | -15.6% |
| Total Liabilities | $24.3M | -29.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.9M | -33.5% |
| Capital Expenditures | $32K | -18.8% |
| Investing Cash Flow | -$4.0M | +62.1% |
| Financing Cash Flow | $8.6M | -41.4% |
| Free Cash Flow | -$10.9M | -33.2% |
| -152.3% |
| EPS (Basic) | -$27.33 | -11.8% |
| Stockholders' Equity |
| -$4.8M |
| -108.0% |